文献速递产科

美国新冠疫苗接种孕妇早产率降低

Reduction in preterm birth among COVID-19-vaccinated pregnant individuals in the United States.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-08-03

本研究利用Vizient临床数据库对2021年1月至2022年4月分娩的孕妇进行倾向性评分匹配队列研究,比较任何新冠疫苗接种组与未接种组的早产率。接种组在<37周、<34周和<28周的早产风险均显著低于未接种组。

要点

  • 接种新冠疫苗与<37周早产风险降低相关(aOR 0.74)。
  • 接种组<34周和<28周早产风险分别降低37%和43%。
  • 倾向性评分匹配后两组人口学特征无差异。

核心结论

  • 新冠疫苗接种可能对早产具有保护作用。

研究设计与样本

  • 基于Vizient临床数据库的队列研究,纳入38个州192家医院2021年1月至2022年4月分娩的孕妇,采用倾向性评分匹配比较接种组与未接种组。

主要发现

  • 匹配后接种组(n=5749)与未接种组在年龄、种族、保险状态、产次及合并症方面无差异。
  • 接种组<37周早产风险比未接种组降低26%(aOR 0.74;95%CI 0.73-0.75;P<.001)。
  • 接种组<34周早产风险比未接种组降低37%(aOR 0.63;95%CI 0.61-0.64;P<.001)。
  • 接种组<28周早产风险比未接种组降低43%(aOR 0.57;95%CI 0.55-0.60;P<0.001)。

关键数值与推荐

  • 完全接种定义为≥2剂Moderna或Pfizer疫苗或至少1剂Johnson & Johnson疫苗;不完全接种定义为1剂Pfizer或Moderna疫苗。
  • 采用多变量logistic回归模型校正潜在混杂因素,效应量为调整比值比(aOR)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most studies investigating preterm birth and COVID-19 vaccination have suggested no difference in preterm birth rates between vaccinated and unvaccinated pregnant individuals; however, 1 recent study suggested a protective effect of COVID-19 vaccination on preterm birth rates in Australia. OBJECTIVE: This study aimed to determine whether a similar association and protective effect of COVID-19 vaccination on preterm birth would be found in our multistate, US cohort. STUDY DESIGN: A cohort study was conducted using the Vizient Clinical Database, which included data from 192 hospitals in 38 states. Pregnant individuals who delivered between January 2021 and April 2022 were included. Propensity score matching was used to match a "treated" group of pregnant individuals with any COVID-19 vaccination (incomplete or complete vaccination) to a group that had not received any COVID-19 vaccination (the "untreated" group). A complete vaccination series of ≥2 doses of the Moderna or Pfizer vaccines or at least 1 dose of the Johnson & Johnson vaccine was considered. An incomplete series was receipt of 1 dose of the Pfizer or Moderna vaccine. We examined the association between COVID-19 vaccination status and preterm birth at <28, <34, and <37 weeks of gestation. Multivariable logistic regression models were used to adjust for potential confounders, with adjusted odds ratios as the measure of treatment effect. RESULTS: Matching with replacement was performed for 5749 treated participants. After propensity score matching, there was no difference in maternal demographics of age, race, insurance status, parity, or comorbid conditions. Vaccinated individuals were 26% less likely to deliver at <37 weeks of gestation (adjusted odds ratio, 0.74; 95% confidence interval, 0.73-0.75; P<.001), 37% less likely to deliver at <34 weeks of gestation (adjusted odds ratio, 0.63; 95% confidence interval, 0.61-0.64; P<.001), and 43% less likely to deliver at <28 weeks of gestation (adjusted odds ratio, 0.57; 95% confidence interval, 0.55-0.60; P<0.001) than unvaccinated individuals. CONCLUSION: Vaccination against COVID-19 may be protective against preterm birth.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Darwin KC, Kohn JR, Shippey E, et al. Reduction in preterm birth among COVID-19-vaccinated pregnant individuals in the United States. Am J Obstet Gynecol MFM. 2023. PMID: 37543141. doi:10.1016/j.ajogmf.2023.101114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。